Beta Drugs Ltd. benchmarking: Perfomance to industry peers

Financial

	Beta Drugs	Bliss GVS Pharma	Syncom Formulations
Operational Metrics
Financials
5 yr Average ROE	21.73 %	6.83 %	9.79 %
5yr average Equity Multiplier	1.75	1.3	1.41
5yr Average Asset Turnover Ratio	1.04	0.62	0.81
5yr Avg Net Profit Margin	11.97 %	8.7 %	8.78 %
Price to Book	0.0	1.55	4.49
P/E	41.48	15.25	26.67
5yr Avg Cash Conversion Cycle	15.7 Days	186.56 Days	61.57 Days
Inventory Days	43.83 Days	54.35 Days	27.32 Days
Days Receivable	87.61 Days	189.93 Days	82.75 Days
Days Payable	113.94 Days	75.78 Days	79.41 Days
5yr Average Interest Coverage Ratio	13.71	14.68	31.44
5yr Avg ROCE	27.85 %	13.27 %	13.63 %
5yr Avg Operating Profit Margin	21.58 %	17.03 %	9.97 %
5 yr average Debt to Equity	0.23	0.11	0.19
5yr CAGR Net Profit	31.07 %	4.24 %	36.24 %
5yr Average Return on Assets	12.53 %	5.31 %	7.11 %
Shareholdings
Promoter Holding	66.73 %	35.39 %	50.57 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.02 %	0.84 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Beta Drugs	Bliss GVS Pharma	Syncom Formulations
Product Wise Break-Up	Product Wise Break-Up Oncology 100.0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 Renting of Property 0 Trading of Commodities 0 Pharmaceutical Drugs & Formulations 0	Product Wise Break-Up Anti Malarials 43.0 Anti-fungal 16.0 Pharmaceutical Drugs & Formulations 0 Oncology 0 Trading of Commodities 0 Anti-bacterial 0 Renting of Property 0 Antibiotics 5.0 Anti Inflammatory 7.0 Others 29.0	Product Wise Break-Up Antimalarial 0 Anti-fungal, 0 Pharmaceutical 98.42 Oncology 0 Commodity 0.85 Anti-bacterial 0 Rental Income 0.73 Anti-biotic 0 Anti Inflammatory 0
Location Wise Break-Up	Location Wise Break-Up India 71.03 Rest of the World 0 India 0 International 0 Others 28.97	Location Wise Break-Up Rest of the World 93.39 International 0 India 6.61	Location Wise Break-Up Rest of the World 0 International 84.5 India 0 Others 15.5